BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 36430951)

  • 1. Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics.
    Gholikhani T; Kumar S; Valizadeh H; Mahdinloo S; Adibkia K; Zakeri-Milani P; Barzegar-Jalali M; Jimenez B
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer selection and applications for breast cancer diagnostics and therapy.
    Liu M; Yu X; Chen Z; Yang T; Yang D; Liu Q; Du K; Li B; Wang Z; Li S; Deng Y; He N
    J Nanobiotechnology; 2017 Nov; 15(1):81. PubMed ID: 29132385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric aptamers in cancer cell-targeted drug delivery.
    Kanwar JR; Roy K; Kanwar RK
    Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
    Zhong Y; Zhao J; Li J; Liao X; Chen F
    Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamers used for biosensors and targeted therapy.
    Ning Y; Hu J; Lu F
    Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Aptamer Discovery and Applications.
    Zhang Y; Lai BS; Juhas M
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30866536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer Technologies in Neuroscience, Neuro-Diagnostics and Neuro-Medicine Development.
    Wang B; Kobeissy F; Golpich M; Cai G; Li X; Abedi R; Haskins W; Tan W; Benner SA; Wang KKW
    Molecules; 2024 Mar; 29(5):. PubMed ID: 38474636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Better Aptamers: Structured Library Approaches, Selection Methods, and Chemical Modifications.
    Brown A; Brill J; Amini R; Nurmi C; Li Y
    Angew Chem Int Ed Engl; 2024 Apr; 63(16):e202318665. PubMed ID: 38253971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Aptamer-Based Biosensors and Cell-Internalizing SELEX Technology for Diagnostic and Therapeutic Application.
    Gan Z; Roslan MAM; Abd Shukor MY; Halim M; Yasid NA; Abdullah J; Md Yasin IS; Wasoh H
    Biosensors (Basel); 2022 Oct; 12(11):. PubMed ID: 36354431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
    Kim M; Kim DM; Kim KS; Jung W; Kim DE
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamers: multifunctional molecules for biomedical research.
    Banerjee J; Nilsen-Hamilton M
    J Mol Med (Berl); 2013 Dec; 91(12):1333-42. PubMed ID: 24045702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugs.
    Urak KT; Shore S; Rockey WM; Chen SJ; McCaffrey AP; Giangrande PH
    Methods; 2016 Jul; 103():167-74. PubMed ID: 26972786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamers: potential applications to pancreatic cancer therapy.
    Rialon KL; White RR
    Anticancer Agents Med Chem; 2011 Jun; 11(5):434-41. PubMed ID: 21492073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Exonucleases for Aptamer Characterization, Engineering, and Sensing.
    Alkhamis O; Canoura J; Ly PT; Xiao Y
    Acc Chem Res; 2023 Jul; 56(13):1731-1743. PubMed ID: 37314701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.
    Reinemann C; Strehlitz B
    Swiss Med Wkly; 2014 Jan; 144():w13908. PubMed ID: 24395443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
    Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
    Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of aptamers for targeted therapeutics.
    Ray P; Viles KD; Soule EE; Woodruff RS
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.